paxalisib   Click here for help

GtoPdb Ligand ID: 10097

Synonyms: compound 16 [PMID: 27096040] | GDC-0084 | GDC0084
Compound class: Synthetic organic
Comment: Paxalisib (GDC0084) is a dual PI3K/mTOR inhibitor that was developed by Genentech [1]. It was designed to cross the blood-brain-barrier as a potential oncology drug for the treatment of malignant gliomas.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 117.1
Molecular weight 382.19
XLogP 1.01
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Nc1ncc(cn1)c1nc(N2CCOCC2)c2c(n1)n1CCOC(c1n2)(C)C
Isomeric SMILES Nc1ncc(cn1)c1nc(N2CCOCC2)c2c(n1)n1CCOC(c1n2)(C)C
InChI InChI=1S/C18H22N8O2/c1-18(2)16-22-12-14(25-3-6-27-7-4-25)23-13(11-9-20-17(19)21-10-11)24-15(12)26(16)5-8-28-18/h9-10H,3-8H2,1-2H3,(H2,19,20,21)
InChI Key LGWACEZVCMBSKW-UHFFFAOYSA-N
References
1. Heffron TP, Ndubaku CO, Salphati L, Alicke B, Cheong J, Drobnick J, Edgar K, Gould SE, Lee LB, Lesnick JD et al.. (2016)
Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR.
ACS Med Chem Lett, 7 (4): 351-6. [PMID:27096040]